Back
Apogee Therapeutics, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Buy
51
APGE
Apogee Therapeutics, Inc.
Last Price:
$71.31
Seasonality Move:
58.17%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsApogee Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 64.4% based on the past 2 years of stock performance.
-
Apogee Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Apogee Therapeutics, Inc. Stock Undervalued?The current Apogee Therapeutics, Inc. [APGE] share price is $79.86. The Score for APGE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
APGE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Apogee Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Apogee Therapeutics, Inc. has on average historically risen by 64.4% based on the past 2 years of stock performance.
Apogee Therapeutics, Inc. Stock Rating
Buy
51
Apogee Therapeutics, Inc. (APGE)
is a Buy
Is Apogee Therapeutics, Inc. overpriced?
-
Apogee Therapeutics, Inc. has risen higher in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Apogee Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apogeetherapeutics.com
52-Week Data
52-Week High:
84.56
52-Week Low:
26.20
Prediction Charts
Market Cap:
4.9B
Price in USD:
79.86
Volume:
687K
Beta:
1.45
Technical Analysis
SMA50:
73.83
SMA100:
59.74
SMA200:
49.02
52-Wk Change:
105.19%
Stock Predictions
-
Is Apogee Therapeutics, Inc. stock public?Yes, Apogee Therapeutics, Inc. is a publicly traded company.
-
What is the Apogee Therapeutics, Inc. stock quote today?The Apogee Therapeutics, Inc. stock price is 79.86 USD today.
-
How to buy Apogee Therapeutics, Inc. stock online?You can buy Apogee Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 75.96 | 75.78 | 76.07 | 73.54 |
| Jan-5 | 75.55 | 77.51 | 77.87 | 72.56 |
| Jan-6 | 75.00 | 78.25 | 80.22 | 72.87 |
| Jan-7 | 78.06 | 78.95 | 80.34 | 76.35 |
| Jan-8 | 78.06 | 77.48 | 78.40 | 75.13 |
| Jan-9 | 78.50 | 77.99 | 80.24 | 77.31 |
| Jan-12 | 77.89 | 77.65 | 78.00 | 75.02 |
| Jan-13 | 77.47 | 79.00 | 80.00 | 77.39 |
| Jan-14 | 78.94 | 82.43 | 84.56 | 78.08 |
| Jan-15 | 82.38 | 80.75 | 83.32 | 80.55 |
| Jan-16 | 80.92 | 80.77 | 81.97 | 80.00 |
| Jan-20 | 78.95 | 82.04 | 82.61 | 76.79 |
| Jan-21 | 81.44 | 81.91 | 82.00 | 79.94 |
| Jan-22 | 79.98 | 79.86 | 81.53 | 77.61 |
Apogee Therapeutics, Inc. Earnings
Apogee Therapeutics, Inc. Earnings Report: Per Share Apogee Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apogee Therapeutics, Inc. Forecast Revenue Growth
Apogee Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Apogee Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.56 per share.
* Apogee Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.